Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Brivaracetam
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Brivaracetam 100mg tablets
0408010ALAAAEAE
|
Brivaracetam | Brivaracetam | Central Nervous System | 13,223 |
|
Brivaracetam 50mg tablets
0408010ALAAACAC
|
Brivaracetam | Brivaracetam | Central Nervous System | 9,350 |
|
Brivaracetam 25mg tablets
0408010ALAAABAB
|
Brivaracetam | Brivaracetam | Central Nervous System | 5,555 |
|
Brivaracetam 75mg tablets
0408010ALAAADAD
|
Brivaracetam | Brivaracetam | Central Nervous System | 3,734 |
|
Brivaracetam 50mg/5ml oral solution sugar free
0408010ALAAAGAG
|
Brivaracetam | Brivaracetam | Central Nervous System | 2,691 |
|
Brivaracetam 10mg tablets
0408010ALAAAAAA
|
Brivaracetam | Brivaracetam | Central Nervous System | 670 |
|
Briviact 100mg tablets
0408010ALBBAEAE
|
Briviact | Brivaracetam | Central Nervous System | 564 |
|
Briviact 50mg tablets
0408010ALBBACAC
|
Briviact | Brivaracetam | Central Nervous System | 438 |
|
Briviact 25mg tablets
0408010ALBBABAB
|
Briviact | Brivaracetam | Central Nervous System | 279 |
|
Briviact 10mg/ml oral solution
0408010ALBBAGAG
|
Briviact | Brivaracetam | Central Nervous System | 192 |
|
Briviact 75mg tablets
0408010ALBBADAD
|
Briviact | Brivaracetam | Central Nervous System | 169 |
|
Briviact 10mg tablets
0408010ALBBAAAA
|
Briviact | Brivaracetam | Central Nervous System | 26 |
|
Brivaracetam 50mg/5ml solution for injection vials
0408010ALAAAFAF
|
Brivaracetam | Brivaracetam | Central Nervous System | 2 |
|
Briviact 50mg/5ml solution for injection vials
0408010ALBBAFAF
|
Briviact | Brivaracetam | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.